The safety of INTANZA has been assessed in 2 open-label randomised clinical trials in which 2,384 vaccinees received an injection of INTANZA.
INTANZA ohutust on hinnatud 2 avatud, randomiseeritud, kliinilises uuringus, mille käigus manustati 2384 uuringus osalejale INTANZA’ d.